跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 40,912 条关于
“Aditxt Inc.”
全部
40,912
临床试验
11,207
药物
1,604
机构
6,169
资讯
21,932
去年
Appili Therapeutics Terminates $1M Acquisition Deal with Aditxt, Secures Loan Extensions
去年
Appili Therapeutics Gains FDA Alignment on ATI-1801 Development for Leishmaniasis
去年
Appili Therapeutics Receives Positive FDA Feedback on ATI-1801 Development for NDA Submission
去年
Appili Therapeutics Gains FDA Alignment on ATI-1801 for Cutaneous Leishmaniasis
去年
Appili Therapeutics Advances ATI-1801 Development for Cutaneous Leishmaniasis with FDA Alignment
去年
Appili Therapeutics Advances Pipeline with FDA-Approved Drug Launch and Vaccine Progress
去年
Evofem Biosciences Secures Patent Protection for SOLOSEC Through 2041, Strengthening Market Position for Single-Dose STI Treatment
6个月前
Aditxt Acquires Ignite Proteomics for $36 Million to Advance Precision Oncology Platform
去年
Aditxt's Adimune Advances DNA-Based Immune Reprogramming Platform with 96 Patents, Eyes 2026 Clinical Trials
去年
Virios Therapeutics and Wex Pharmaceuticals Merge to Form Dogwood Therapeutics, Advancing Novel Pain and Viral Therapies
第 1 页,共 2194 页
上一页
下一页